Skip to main content

Velcura Receives Grant for Proteomics Research on Bone Formation

NEW YORK, Oct. 6 (GenomeWeb News) - Velcura Therapeutics said today that it has received a $224,000 phase I small business innovation research grant from the National Institute on Aging.

 

The company said the six-month grant - entitled "Regulation of the Human Osteoblast Proteome" - will support its research of the molecular processes underlying human bone formation.

 

Velcura's research will be done in collaboration with Proteomics Research Services, according to the company's CEO Michael Long.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.